Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 73093 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y, (12 

CFR part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. 

Comments received are subject to 

public disclosure. In general, comments 

received will be made available without 

change and will not be modified to 

remove personal or business 

information including confidential, 

contact, or other identifying 

information. Comments should not 

include any information such as 

confidential information that would not 

be appropriate for public disclosure. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors, 

Ann E. Misback, Secretary of the Board, 

20th Street and Constitution Avenue 

NW, Washington, DC 20551–0001, not 

later than September 24, 2024. 

A. Federal Reserve Bank of Cleveland 

(Nadine M. Wallman, Vice President) 

1455 East Sixth Street, Cleveland, Ohio 

44101–2566. Comments can also be sent 

electronically to 

Comments.applications@clev.frb.org: 

1. The PNC Financial Services Group, 

Inc., Pittsburgh, Pennsylvania; to engage 

in community development activities 

up to 15 percent of total consolidated 

capital and surplus pursuant to section 

225.28(b)(12) of the Board’s Regulation 

Y. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Associate Secretary of the Board. 

[FR Doc. 2024–20255 Filed 9–6–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–1430] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘B. multivorans 

Ice Machine Multistate Investigation’’ to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on April 12, 2024 to obtain 

comments from the public and affected 

agencies. CDC did not receive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

B. Multivorans Ice Machine Multistate 

Investigation (OMB Control No. 0920– 

1430, Exp. 9/30/2024)—Extension— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

CDC has been assisting state and local 

jurisdictions investigate clusters of 

Burkholderia multivorans infections 

among patients admitted across four 

hospitals in two non-contiguous states. 

The outbreak strain of the bacteria has 

been identified in environmental 

samples from ice machines. Molecular 

analysis has shown that the bacterial 

strain identified in ice machines is 

genetically highly similar to the patient 

isolates. Further investigation revealed 

that the same brand of ice machine and 

the same filters, descaling/cleaning, and 

sanitizing products were used by the 

four hospitals. Epidemiologic and 

laboratory evidence suggest the 

possibility of contaminated nonsterile 

ice and water from the same brand of ice 

machines as a common source of 

exposure. 

Further investigation is needed to 

identify the scope of the outbreak and 

the source of the ice machine 

contamination. CDC has deemed it 

necessary to conduct a national call for 

cases requesting that public health 

authorities report cases and clusters of 

B. multivorans. A case report form was 

developed by CDC to assist jurisdictions 

in this effort. Jurisdictions will gather 

information using this case report form 

to assist in determining epidemiologic 

characteristics and risk factors of 

patients with B. multivorans as well as 


ddrumheller on DSK120RN23PROD with NOTICES1
73094 Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 

potential source(s) of B. multivorans, 

including ice machines and ice 

machine-related products (e.g., cleaning 

solutions). This data collection will 

enable CDC to better ascertain risk 

factors for transmission, potential 

source(s) of ice machine contamination, 

and develop targeted infection 

prevention and control 

recommendations to stop the 

transmission of the bacteria. Since this 

non-research public health response 

remains active, CDC requests approval 

for continued information collection 

activities for a period of three years. 

There are no proposed changes to the 

current information collection 

instrument. CDC requests OMB 

approval for an estimated 120 

annualized burden hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Health department healthcare-associated infections/antimicrobial resistance (HAI/AR) 

program staff/epidemiologists.

B. multivorans outbreak investigation case 

report form.

40 1 3 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–20245 Filed 9–6–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Mine Safety and Health 

Research Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Mine Safety 

and Health Research Advisory 

Committee (MSHRAC). This is a hybrid 

meeting, accessible both in person and 

virtually. It is open to the public and 

limited only by the space available and 

the number of web conference lines 

available. Time will be available for 

public comment. 

DATES: The meeting will be held on 

November 7, 2024, from 8:30 a.m. to 

4:10 p.m., EST. 

ADDRESSES: University of Kentucky, 

Mining and Minerals Resources 

Building, Room 102, 310 Columbia 

Avenue, Lexington, Kentucky 40508. 

The conference room accommodates 

approximately 100 people. 

If you wish to attend the meeting 

either in person or virtually, please 

contact Ms. Berni Metzger by email at 

Metzger@cdc.gov or by phone at (412) 

386–4541 at least 5 business days in 

advance of the meeting. If you are 

attending virtually, she will provide you 

with the Zoom web conference access 

information (500 web conference lines 

are available). 

FOR FURTHER INFORMATION CONTACT: 

Steven Mischler, Ph.D., Designated 

Federal Officer, Mine Safety and Health 

Research Advisory Committee, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 626 Cochrans Mill Road, 

Pittsburgh, Pennsylvania 15236. 

Telephone: (412) 386–5688; Email: 

SMischler@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Mine Safety and Health 

Research Advisory Committee 

(MSHRAC) is charged with providing 

advice to the Secretary, Department of 

Health and Human Services; the 

Director, Centers for Disease Control 

and Prevention; and the Director, 

National Institute for Occupational 

Safety and Health (NIOSH), on priorities 

in mine safety and health research, 

including grants and contracts for such 

research, 30 U.S.C. 812(b)(2). 

Matters to be Considered: The agenda 

will include discussions on NIOSH 

mining safety and health research 

organizational structure, capabilities, 

projects, and outcomes; discussions on 

intramural and extramural silica 

research; and a verbal report from 

MSHRAC’s Mace Underground Mine 

Safety and Health Research Laboratory 

Development Workgroup. The meeting 

will also include an update from the 

NIOSH Associate Deputy Director, Mine 

Safety and Research. Agenda items are 

subject to change as priorities dictate. 

Public Participation 

Written Public Comment: The public 

may submit written comments or 

questions in advance of the meeting, to 

the Designated Federal Officer (see FOR

FURTHER INFORMATION CONTACT above). 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting, and 

questions will be answered during the 

oral comment period open to public 

participation. 

Oral Public Comment: The meeting 

will include time for members of the 

public to make an oral comment. The 

public comment session will be held on 

November 7, 2024, at 3:30 p.m., EST, or 

the conclusion of the planned 

presentations, whichever comes first. 

Members of the public will be allocated 

5 to 10 minutes each for presentations 

or comments, as a function of the 

number of commenters. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–20253 Filed 9–6–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Clinical Laboratory 

Improvement Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 


ddrumheller on DSK120RN23PROD with NOTICES1